位置:首页 > 蛋白库 > UBIP1_HUMAN
UBIP1_HUMAN
ID   UBIP1_HUMAN             Reviewed;         540 AA.
AC   Q9NZI7; Q68CT0; Q86Y57; Q9H8V0; Q9UD76; Q9UD78;
DT   21-MAR-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   03-AUG-2022, entry version 162.
DE   RecName: Full=Upstream-binding protein 1;
DE   AltName: Full=Transcription factor LBP-1;
GN   Name=UBP1; Synonyms=LBP1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), FUNCTION, SUBCELLULAR
RP   LOCATION, AND VARIANT SER-109.
RX   PubMed=8114710; DOI=10.1128/mcb.14.3.1776-1785.1994;
RA   Yoon J.-B., Li G., Roeder R.G.;
RT   "Characterization of a family of related cellular transcription factors
RT   which can modulate human immunodeficiency virus type 1 transcription in
RT   vitro.";
RL   Mol. Cell. Biol. 14:1776-1785(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, AND TISSUE SPECIFICITY.
RC   TISSUE=Placenta;
RX   PubMed=10644752; DOI=10.1074/jbc.275.4.2852;
RA   Huang N., Miller W.L.;
RT   "Cloning of factors related to HIV-inducible LBP proteins that regulate
RT   steroidogenic factor-1-independent human placental transcription of the
RT   cholesterol side-chain cleavage enzyme, P450scc.";
RL   J. Biol. Chem. 275:2852-2858(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT ALA-212.
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 394-540.
RC   TISSUE=Amygdala;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [6]
RP   FUNCTION, AND INDUCTION.
RX   PubMed=2006421; DOI=10.1126/science.2006421;
RA   Kato H., Horikoshi M., Roeder R.G.;
RT   "Repression of HIV-1 transcription by a cellular protein.";
RL   Science 251:1476-1479(1991).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-22, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: Functions as a transcriptional activator in a promoter
CC       context-dependent manner. Modulates the placental expression of
CC       CYP11A1. Involved in regulation of the alpha-globin gene in erythroid
CC       cells. Activation of the alpha-globin promoter in erythroid cells is
CC       via synergistic interaction with TFCP2 (By similarity). Involved in
CC       regulation of the alpha-globin gene in erythroid cells. Binds strongly
CC       to sequences around the HIV-1 initiation site and weakly over the TATA-
CC       box. Represses HIV-1 transcription by inhibiting the binding of TFIID
CC       to the TATA-box. {ECO:0000250, ECO:0000269|PubMed:10644752,
CC       ECO:0000269|PubMed:2006421, ECO:0000269|PubMed:8114710}.
CC   -!- SUBUNIT: Interacts with TFCP2. Interacts with PIAS1, and is probably
CC       part of a complex containing TFCP2, UBP1 and PIAS1 (By similarity).
CC       {ECO:0000250}.
CC   -!- INTERACTION:
CC       Q9NZI7; Q8TBB1: LNX1; NbExp=3; IntAct=EBI-2795133, EBI-739832;
CC       Q9NZI7; Q9UBU8-2: MORF4L1; NbExp=3; IntAct=EBI-2795133, EBI-10288852;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:8114710}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1; Synonyms=LBP-1b;
CC         IsoId=Q9NZI7-1; Sequence=Displayed;
CC       Name=2; Synonyms=LBP-1a;
CC         IsoId=Q9NZI7-4; Sequence=VSP_017730;
CC   -!- TISSUE SPECIFICITY: Expressed in adrenal tissue, JEG-3, NCI-H295A, Hep-
CC       G2 and HeLa cell lines. {ECO:0000269|PubMed:10644752}.
CC   -!- INDUCTION: By HIV-1 infection of lymphocytes.
CC       {ECO:0000269|PubMed:2006421}.
CC   -!- SIMILARITY: Belongs to the grh/CP2 family. CP2 subfamily.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF198487; AAF32274.1; -; mRNA.
DR   EMBL; AK023274; BAB14501.1; -; mRNA.
DR   EMBL; BC047235; AAH47235.1; -; mRNA.
DR   EMBL; CR749798; CAH18658.1; -; mRNA.
DR   CCDS; CCDS2659.1; -. [Q9NZI7-1]
DR   CCDS; CCDS46788.1; -. [Q9NZI7-4]
DR   PIR; A56205; A56205.
DR   PIR; B56205; B56205.
DR   RefSeq; NP_001121632.1; NM_001128160.1. [Q9NZI7-4]
DR   RefSeq; NP_001121633.1; NM_001128161.1. [Q9NZI7-1]
DR   RefSeq; NP_055332.3; NM_014517.4. [Q9NZI7-1]
DR   AlphaFoldDB; Q9NZI7; -.
DR   SMR; Q9NZI7; -.
DR   BioGRID; 113189; 70.
DR   IntAct; Q9NZI7; 30.
DR   MINT; Q9NZI7; -.
DR   STRING; 9606.ENSP00000283629; -.
DR   GlyGen; Q9NZI7; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q9NZI7; -.
DR   PhosphoSitePlus; Q9NZI7; -.
DR   BioMuta; UBP1; -.
DR   DMDM; 74719655; -.
DR   EPD; Q9NZI7; -.
DR   jPOST; Q9NZI7; -.
DR   MassIVE; Q9NZI7; -.
DR   MaxQB; Q9NZI7; -.
DR   PaxDb; Q9NZI7; -.
DR   PeptideAtlas; Q9NZI7; -.
DR   PRIDE; Q9NZI7; -.
DR   ProteomicsDB; 83408; -. [Q9NZI7-1]
DR   ProteomicsDB; 83409; -. [Q9NZI7-4]
DR   Antibodypedia; 11705; 341 antibodies from 29 providers.
DR   DNASU; 7342; -.
DR   Ensembl; ENST00000283628.9; ENSP00000283628.5; ENSG00000153560.12. [Q9NZI7-1]
DR   Ensembl; ENST00000283629.8; ENSP00000283629.3; ENSG00000153560.12. [Q9NZI7-1]
DR   Ensembl; ENST00000447368.6; ENSP00000395558.2; ENSG00000153560.12. [Q9NZI7-4]
DR   GeneID; 7342; -.
DR   KEGG; hsa:7342; -.
DR   MANE-Select; ENST00000283629.8; ENSP00000283629.3; NM_014517.5; NP_055332.3.
DR   UCSC; uc003cfq.5; human. [Q9NZI7-1]
DR   CTD; 7342; -.
DR   DisGeNET; 7342; -.
DR   GeneCards; UBP1; -.
DR   HGNC; HGNC:12507; UBP1.
DR   HPA; ENSG00000153560; Low tissue specificity.
DR   MIM; 609784; gene.
DR   neXtProt; NX_Q9NZI7; -.
DR   OpenTargets; ENSG00000153560; -.
DR   PharmGKB; PA37154; -.
DR   VEuPathDB; HostDB:ENSG00000153560; -.
DR   eggNOG; KOG4091; Eukaryota.
DR   GeneTree; ENSGT00940000156148; -.
DR   HOGENOM; CLU_015127_2_0_1; -.
DR   InParanoid; Q9NZI7; -.
DR   OMA; INHVYRQ; -.
DR   PhylomeDB; Q9NZI7; -.
DR   TreeFam; TF314132; -.
DR   PathwayCommons; Q9NZI7; -.
DR   SignaLink; Q9NZI7; -.
DR   BioGRID-ORCS; 7342; 20 hits in 1101 CRISPR screens.
DR   ChiTaRS; UBP1; human.
DR   GenomeRNAi; 7342; -.
DR   Pharos; Q9NZI7; Tbio.
DR   PRO; PR:Q9NZI7; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   RNAct; Q9NZI7; protein.
DR   Bgee; ENSG00000153560; Expressed in tibia and 200 other tissues.
DR   ExpressionAtlas; Q9NZI7; baseline and differential.
DR   Genevisible; Q9NZI7; HS.
DR   GO; GO:0000785; C:chromatin; ISA:NTNU_SB.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:GO_Central.
DR   GO; GO:0001228; F:DNA-binding transcription activator activity, RNA polymerase II-specific; IDA:GO_Central.
DR   GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; ISA:NTNU_SB.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; IDA:GO_Central.
DR   GO; GO:1990837; F:sequence-specific double-stranded DNA binding; IDA:ARUK-UCL.
DR   GO; GO:0001525; P:angiogenesis; IEA:Ensembl.
DR   GO; GO:0032897; P:negative regulation of viral transcription; IDA:GO_Central.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IDA:GO_Central.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IDA:GO_Central.
DR   CDD; cd09588; SAM_LBP1; 1.
DR   Gene3D; 1.10.150.50; -; 1.
DR   InterPro; IPR007604; CP2.
DR   InterPro; IPR013761; SAM/pointed_sf.
DR   InterPro; IPR041418; SAM_3.
DR   InterPro; IPR037600; Ubp1_SAM.
DR   Pfam; PF04516; CP2; 1.
DR   Pfam; PF18016; SAM_3; 1.
DR   SUPFAM; SSF47769; SSF47769; 1.
DR   PROSITE; PS51968; GRH_CP2_DB; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; DNA-binding; Nucleus; Phosphoprotein;
KW   Reference proteome; Transcription; Transcription regulation.
FT   CHAIN           1..540
FT                   /note="Upstream-binding protein 1"
FT                   /id="PRO_0000229026"
FT   DOMAIN          60..296
FT                   /note="Grh/CP2 DB"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01313"
FT   REGION          236..270
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          285..368
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        236..264
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        316..368
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         22
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   MOD_RES         390
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q811S7"
FT   MOD_RES         393
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q811S7"
FT   VAR_SEQ         274..309
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:8114710"
FT                   /id="VSP_017730"
FT   VARIANT         109
FT                   /note="N -> S (in dbSNP:rs3736563)"
FT                   /evidence="ECO:0000269|PubMed:8114710"
FT                   /id="VAR_049294"
FT   VARIANT         212
FT                   /note="T -> A (in dbSNP:rs17854430)"
FT                   /evidence="ECO:0000269|PubMed:15489334"
FT                   /id="VAR_025730"
FT   CONFLICT        93..94
FT                   /note="EI -> D (in Ref. 3; BAB14501)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        273
FT                   /note="E -> EE (in Ref. 1)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        291..297
FT                   /note="SSKRTLP -> VQQADFA (in Ref. 1)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        418
FT                   /note="Y -> V (in Ref. 1)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        424
FT                   /note="R -> RR (in Ref. 5; CAH18658)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        503
FT                   /note="G -> GH (in Ref. 1)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   540 AA;  60491 MW;  CD95819AA86A7F39 CRC64;
     MAWVLKMDEV IESGLVHDFD ASLSGIGQEL GAGAYSMSDV LALPIFKQED SSLPLDGETE
     HPPFQYVMCA ATSPAVKLHD ETLTYLNQGQ SYEIRMLDNR KMGDMPEING KLVKSIIRVV
     FHDRRLQYTE HQQLEGWKWN RPGDRLLDLD IPMSVGIIDT RTNPSQLNAV EFLWDPAKRT
     SAFIQVHCIS TEFTPRKHGG EKGVPFRIQV DTFKQNENGE YTDHLHSASC QIKVFKPKGA
     DRKQKTDREK MEKRTAHEKE KYQPSYDTTI LTEMRLEPII EDAVEHEQKK SSKRTLPADY
     GDSLAKRGSC SPWPDAPTAY VNNSPSPAPT FTSPQQSTCS VPDSNSSSPN HQGDGASQTS
     GEQIQPSATI QETQQWLLKN RFSSYTRLFS NFSGADLLKL TKEDLVQICG AADGIRLYNS
     LKSRSVRPRL TIYVCREQPS STVLQGQQQA ASSASENGSG APYVYHAIYL EEMIASEVAR
     KLALVFNIPL HQINQVYRQG PTGIHILVSD QMVQNFQDES CFLFSTVKAE SSDGIHIILK
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024